Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观液透析滤过(HDF)及液透析(HD)对尿毒症脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有液透析和腹膜透析两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观液透析滤过(HDF)对老年透析患者心管稳定性的影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：液透析和尿毒症对肿瘤志物水平的影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观12用人造管内瘘行液透析的患者,针对其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠症患者如果利尿效果不佳或合并有心力衰竭或高容量时,可以考虑液透析治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高对长期液透析患者获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影响出热病人急性肾衰少尿期预后的因素及液透析在出热病人中的应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的观肾康注射液治疗慢性肾功能衰竭的疗效,为控制慢性肾衰患者肾衰进程而延缓进行液透析提供一个好的方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观察液透滤过(HDF)及液透(HD)对尿毒脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有液透和腹膜透。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察液透滤过(HDF)对老年透者心管稳定性的影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：了解液透和尿毒对肿瘤志物水平的影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例使用人造管内瘘行液透的者,针对其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠者如果利尿效果不佳或合并有心力衰竭或高容量时,可以考虑液透治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高对长期液透者获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影响出热病人急性肾衰少尿期预后的因素及液透在出热病人中的应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的观察肾康注射液治疗慢性肾功能衰竭的疗效,为控制慢性肾衰者肾衰进程而延缓进行液透提供一个好的方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观察血液滤过(HDF)及血液(HD)对尿毒症脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

法主要有血液腹膜两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察血液滤过(HDF)对老年患者心血管稳定性的影。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：了解血液尿毒症对肿瘤志物水平的影。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

法观察12例使用人造血管内瘘行血液的患者,针对其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠血症患者如果利尿效果不佳或合并有心力衰竭或高血容量时,可以考虑血液治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高对长期血液患者获得性肾囊肿及肾细胞癌的发病临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影出血热病人急性肾衰少尿期预后的因素及血液在出血热病人中的应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的观察肾康注射液治疗慢性肾功能衰竭的疗效,为控制慢性肾衰患者肾衰进程而延缓进行血液提供一个好的法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观液透析滤过(HDF)及液透析(HD)对尿毒症脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有液透析和腹膜透析两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观液透析滤过(HDF)对老年透析患者心管稳定性的影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：液透析和尿毒症对肿瘤志物水平的影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观12用人造管内瘘行液透析的患者,针对其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠症患者如果利尿效果不佳或合并有心力衰竭或高容量时,可以考虑液透析治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高对长期液透析患者获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影响出热病人急性肾衰少尿期预后的因素及液透析在出热病人中的应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的观肾康注射液治疗慢性肾功能衰竭的疗效,为控制慢性肾衰患者肾衰进程而延缓进行液透析提供一个好的方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观察血滤过(HDF)及血(HD)对尿毒症脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有血和腹膜两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察血滤过(HDF)对老年患者心血管稳定性的影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：了解血和尿毒症对肿瘤志物水平的影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例使用人造血管内瘘行血的患者,针对其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠血症患者如果利尿效果不佳或合并有心力衰竭或高血容量时,可以考虑血疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高对长期血患者获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影响出血热病人急性肾衰少尿期预后的因素及血在出血热病人中的应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的观察肾康注射疗慢性肾功能衰竭的疗效,为控制慢性肾衰患者肾衰进程而延缓进行血提供一个好的方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观察血滤过(HDF)及血(HD)对尿毒症脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有血和腹膜两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察血滤过(HDF)对老年患者心血管稳定性的影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：了解血和尿毒症对肿瘤志物水平的影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例使用人造血管内瘘行血的患者,针对其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠血症患者如果利尿效果不佳或合并有心力衰竭或高血容量时,可以考虑血疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高对长期血患者获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影响出血热病人急性肾衰少尿期预后的因素及血在出血热病人中的应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的观察肾康注射疗慢性肾功能衰竭的疗效,为控制慢性肾衰患者肾衰进程而延缓进行血提供一个好的方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观察液透滤过(HDF)及液透(HD)对尿毒脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有液透和腹膜透。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察液透滤过(HDF)对老年透者心管稳定性的影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：了解液透和尿毒对肿瘤志物水平的影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例使用人造管内瘘行液透的者,针对其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠者如果利尿效果不佳或合并有心力衰竭或高容量时,可以考虑液透治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高对长期液透者获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影响出热病人急性肾衰少尿期预后的因素及液透在出热病人中的应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的观察肾康注射液治疗慢性肾功能衰竭的疗效,为控制慢性肾衰者肾衰进程而延缓进行液透提供一个好的方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的察液透析滤过(HDF)及液透析(HD)对尿毒脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有液透析和腹膜透析。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

察液透析滤过(HDF)对老年透析患者心管稳定性的影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：了解液透析和尿毒对肿瘤志物水平的影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法察12例使用人造管内瘘行液透析的患者,针对其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低患者如果利尿效果不佳或合并有心力衰竭或高容量时,可以考虑液透析治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高对长期液透析患者获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影响出热病人急性肾衰少尿期预后的因素及液透析在出热病人中的应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的察肾康注射液治疗慢性肾功能衰竭的疗效,为控制慢性肾衰患者肾衰进程而延缓进行液透析提供一个好的方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目观察血液透析滤过(HDF)及血液透析(HD)对尿毒症疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有血液透析和腹膜透析两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察血液透析滤过(HDF)对老年透析患者心血管稳定性影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目：了解血液透析和尿毒症对肿瘤志物水平影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例使用人造血管内瘘行血液透析患者,针对其内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠血症患者如果利尿效果不佳合并有心力高血容量时,可以考虑血液透析治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目 提高对长期血液透析患者获得性肾囊肿及肾细胞癌发和临床特点认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目探讨影响出血热人急性肾少尿期预后因素及血液透析在出血热人中应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目观察肾康注射液治疗慢性肾功能疗效,为控制慢性肾患者肾进程而延缓进行血液透析提供一个好方法。

Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观察血液透滤过(HDF)及血液透(HD)尿毒症脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有血液透和腹膜透两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察血液透滤过(HDF)老年透心血管稳定性的影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：了解血液透和尿毒症肿瘤志物水平的影响。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例使用人造血管内瘘行血液透的,内瘘情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠血症如果利尿效果不佳或合并有心力衰竭或高血容量时,可以考虑血液透治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高长期血液透获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影响出血热病人急性肾衰少尿期预后的因素及血液透在出血热病人中的应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的观察肾康注射液治疗慢性肾功能衰竭的疗效,为控制慢性肾衰肾衰进程而延缓进行血液透提供一个好的方法。